Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience

CONTEXT: Acromegaly is a rare, chronic, debilitating disorder caused by prolonged hypersecretion of growth hormone (GH) and overproduction of insulin-like growth factor I (IGF-I). Medical therapies, including the somatostatin receptor ligand (SRL) pasireotide, are frequently used to restore biochemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Mônica, Marques, Nelma Verônica, Fialho, Christhiane, Scaf, Cristiane, Lamback, Elisa, Antunes, Ximene, Santos, Erica, Magalhães, Jaqueline, Wildemberg, Luiz Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655523/
https://www.ncbi.nlm.nih.gov/pubmed/37357993
http://dx.doi.org/10.1210/clinem/dgad378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655523/
https://www.ncbi.nlm.nih.gov/pubmed/37357993
http://dx.doi.org/10.1210/clinem/dgad378

Ejemplares similares